Hudock, Inc. Novo Cure LTD Transaction History
Hudock, Inc.
- $578 Million
- Q3 2024
Shares
2 transactions
Others Institutions Holding NVCR
# of Institutions
263Shares Held
77MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$389 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$380 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$254 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$138 Million0.01% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$97.3 Million12.67% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $3.37B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...